Efficacy and safety of olomorasib with pembrolizumab + chemotherapy as first-line treatment in patients with KRAS G12C-mutant advanced NSCLC Meeting Abstract

  

Authors:	Fujiwara, Y.; Reddy Ammakkanavar, N.; Hollebecque, A.; Murciano-Goroff, Y. R.; Lee, D. H.; Burns, T. F.; Cassier, P.; Han, J. Y.; Italiano, A.; Koyama, T.; Shim, B. Y.; Heist, R. S.; Sabari, J. K.; Spira, A. I.; Bodor, J.; Chu, Q.; Durm, G.; Singhal, N.; Chisamore, M. J.; Fink, A.; Chen, A.; Willard, M. D.; Oxnard, G. R.; Dragnev, K. H.
Abstract Title:	Efficacy and safety of olomorasib with pembrolizumab + chemotherapy as first-line treatment in patients with KRAS G12C-mutant advanced NSCLC
Meeting Title:	2024 World Conference on Lung Cancer
Journal Title:	Journal of Thoracic Oncology
Volume:	19
Issue:	10 Suppl.
Meeting Dates:	2024 Sep 7-10
Meeting Location:	San Diego, CA
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2024-10-01
Start Page:	S41
End Page:	S42
Language:	English
DOI:	10.1016/j.jtho.2024.09.073
PROVIDER:	EBSCOhost
PROVIDER:	cinahl plus with full text
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=rzh&AN=180334905&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting Abstract: OA14.04 -- Source: CINAHL Plus with Full Text

https://synapse.mskcc.org/synapse/works/has_related_data_chk/220276